Target intelligence / Profile preview

Blood plasma toxins and inflammatory mediators

Molecular classification
Cytokine, Lipopolysaccharide, Metabolite, Protein, Other
01

Overview

Blood plasma toxins and inflammatory mediators refer to a broad spectrum of pathogenic molecules that accumulate in the systemic circulation during acute and chronic disease states. This category encompasses pathogen-associated molecular patterns (PAMPs) like endotoxins, damage-associated molecular patterns (DAMPs), and a wide array of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α [1][3]. These mediators are pivotal in driving the dysregulated host response seen in sepsis, cytokine release syndrome (CRS), and multi-organ dysfunction syndrome (MODS) [2]. From a therapeutic perspective, these substances are targeted either through specific pharmacological inhibition using monoclonal antibodies or through broad-spectrum extracorporeal removal techniques like hemoperfusion and high-cutoff hemodialysis [4][6]. The primary challenge in targeting this group lies in the double-edged sword nature of the immune response, where excessive removal may impair necessary host defense mechanisms or inadvertently clear essential medications [5]. Managing the levels of these toxins is crucial for stabilizing critically ill patients and preventing the progression of inflammatory cascades [6]. Sources: [1] Chousterman BG, et al. (2017). Cytokine Storm and Sepsis Disease Pathogenesis. Seminars in Immunopathology. [2] Singer M, et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. [3] Ronco C, et al. (2017). Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient. Nature Reviews Nephrology. [4] Monard C, et al. (2023). Extracorporeal Cytokine Adsorption in Septic Shock. Critical Care. [5] Vanholder R, et al. (2003). Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney International. [6] Rimmelé T, et al. (2023). Extracorporeal Blood Purification Therapy for Sepsis. Blood Purification.

Other names
Inflammatory mediatorsUremic toxinsCirculating endotoxinsCytokines and chemokinesPAMPs and DAMPsSeptic toxinsHumoral mediators
02

Mechanism of action

Extracorporeal adsorption, filtration, or pharmacological neutralization of circulating pathogenic molecules to mitigate systemic inflammation and prevent organ damage [3][4].

03

Biological functions

Immune responseInflammationSignal transductionHomeostasisCoagulation
04

Disease associations

SepsisCytokine stormSystemic Inflammatory Response SyndromeAcute kidney injuryLiver failureInfectionChronic kidney disease
05

Safety considerations

Non-specific removal of therapeutic drugs such as antibioticsDepletion of beneficial anti-inflammatory mediators or nutrientsPotential for circuit-induced hemolysis or thrombocytopeniaRequirement for systemic anticoagulation during extracorporeal therapyHypotension and hemodynamic instability during treatment
06

Interacting drugs

Tocilizumab

7 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)C-reactive protein (CRP)Procalcitonin (PCT)Tumor Necrosis Factor-alpha (TNF-alpha)LactateCreatinine

Beyond the preview

Go deeper on Blood plasma toxins and inflammatory mediators.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood plasma toxins and inflammatory mediators.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call